Upcoming Events

Canadian Society of Nephrology (CSN)

May 4-6, 2017
Montreal, Canada

Observational Clinical Research in CKD and ESRD: Within Canada and Beyond

May 6, 2017 at 1:00 p.m. 
        


       

European Renal Association / European Dialysis and Transplant Association (ERA-EDTA)

June 3-6, 2017
Madrid, Spain

Visit the DOPPS booth 1.065

Symposium: Optimizing care in advanced CKD and the transition to dialysis: Insights from DOPPS Program

June 5, 2017 at 3:15 p.m. Topics and Speakers:
  • The DOPPS Program: invitation to collaborators: Hugh Rayner
  • CKDopps: Improving outcomes in advanced CKD and the transition to dialysis: Helmut Reichel
  • DOPPS: Impact of clinical practices on early mortality among HD patients: Takeshi Hasegawa
  • PDOPPS: Predictors of early successful PD use: Martin Wilkie
  • Recent results from the EURODOPPS: Ayesha Sajjad
     

Free Communications

Sunday, June 4

  • Cinacalcet discontinuation and its predictors in hemodialysis patients: Results from 7 European countries (#SO034). Session: CKD-MBD in dialysis (3:15 p.m.)
  • Regional variation in mineral and bone disorder (MBD) markers and treatment at dialysis start: Results from the DOPPS (#SO032). Session: CKD-MBD in dialysis (3:15 p.m.)
  • Dialysate calcium concentration <3.0mEq/L is not associated with improved outcomes in the Japan DOPPS (#SO061). Session: Epidemiology in dialysis – 2 (5:00-6:30 p.m.)
  • Early Peritoneal Dialysis Attrition: Preliminary Results from The Peritoneal DOPPS (#MO061). Session: Peritoneal dialysis (5:00 p.m.)

Monday, June 5

  • International differences in time from arteriovenous fistula (AVF) creation until becoming catheter-free among HD patients using a catheter at time of AVF creation: Results from the DOPPS (#MO047). Session: Vascular Access (3:15 p.m.)

 

Posters

Sunday, June 4, 9:30-10:45 a.m.

  • Associations of coping strategies with quality of life, depression and mortality among hemodialysis patients in the DOPPS (#SP623)
  • Hypokalemia in the Peritoneal Dialysis and Outcome Practice Patterns Study (PDOPPS): International variability and clinical predictors (#SP498)
  • International variation in PD catheter practices: Preliminary results from the Peritoneal DOPPS (#SP503)
  • Renin-angiotensin-aldosterone system inhibitors (RAASi) and clinical outcomes in hemodialysis patients: Results from the DOPPS (#SP551)
  • Treatments of mineral and bone disorder may be under-utilized in CKD patients (#SP369)

 

Monday, June 5, 9:30-10:45 a.m.

  • Prevalence of hyperkalemia in DOPPS: A real-world, international cohort of hemodialysis patients (#MP371)
  • Renin-angiotensin-aldosterone system inhibitor prescription patterns in hemodialysis patients: Results from the International DOPPS (#MP385)
  • Variation in Renin Angiotensin Aldosterone System Inhibitor (RAASi) prescription internationally and across CKD stages (#MP409)


Japanese Society for Dialysis Therapy (JSDT)

June 16-18, 2017
Yokohama, Japan

        


Past Events

National Kidney Foundation Spring Clinical Meetings

April 18-22, 2017
Walt Disney World Swan and Dolphin
Orlando, FL

Visit the DOPPS booth #453

The DOPPS Program: Study Growth Reveals New Insights

Friday, April 21 at 4:00 p.m. - Session 286

Topics and Speakers:

  • Key Lessons from the First 20 Years of DOPPS: Ronald Pisoni, PhD, MS
  • The Latest in U.S. Hemodialysis Practices: Insights from the DOPPS Practice Monitor: Steven Brunelli, MD
  • PDOPPS: PD Practices and Outcomes that Stand Out in U.S. vs. Internationally: Jeffrey Perl, MD, SM, FRCPC
  • CKDopps: Optimizing Advanced CKD Practices and the Transition to Dialysis: Rachel Perlman, MD


American Society of Nephrology Kidney Week 2016

November 15-20, 2016
Chicago, IL

Featured Posters

          
International variation in dialysis discontinuation: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) (Abstract #TH-PO1108) Click to view poster   Association between diuretic use and residual kidney function in peritoneal dialysis patients: International comparison from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (Abstract #SA-PO1102) Click to view poster
 
 Also Presented
  • Prevalence and dosing patterns of ESAs used in 9 European countries: DOPPS (Abstract #SA-PO1007)
  • Hyperkalemia and prescription of antihypertensive medications: Early findings from the Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps) (Abstract #SA-PO796)
  • International variations in the frequency of the types of patient-physician contact for CKD patients: Early findings from CKDopps (Abstract #SA-PO927)
  • Geographical and seasonal patterns of blood pressure in hemodialysis patients: A EURODOPPS study (Abstract #TH-PO990)
  •  Higher phosphorus is associated with lower hemoglobin in CKD stages 3-5: Early results from the Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps) (Abstract #FR-PO789)
  •  Facility use of low dialysate temperature for prevention of intra-dialytic hypotension is associated with lower cardiovascular mortality in the DOPPS (Abstract #FR-PO938)